| JOURNAL HOME | CME HOME | THIS MONTH | PAST ISSUES | ETOC | COLLECTIONS |
| AUTHORS | REVIEWERS | EDITORIAL BOARD | FEEDBACK | RSS | HELP |
| ||||||||||||||
| ||||||||||||||
|
|
|
|
||||||||||||
|
||||||||||||||
Anesthesia & Analgesia, Vol 83, 304-313, Copyright © 1996 by International Anesthesia Research Society
GENERAL ARTICLES |
J Tang, MF Watcha and PF White
Department of Anesthesiology and Pain Management, University of Texas, Southwestern Medical Center at Dallas 75235-9068, USA.
Ondansetron and droperidol are both effective prophylactic antiemetics for gynecologic outpatient procedures. However, increased drowsiness, delayed discharge, and postdischarge restlessness may occur with droperidol, and ondansetron is costly. In this prospective, randomized, double-blind, placebo-controlled study involving 161 women, we compared the efficacy, safety, and cost-effectiveness of ondansetron (4 mg intravenously [i.v.] with droperidol (0.65 mg or 1.25 mg i.v.) in the prevention of postoperative nausea and vomiting (PONV) after outpatient gynecologic surgery. The incidence of PONV, times to achieving preset recovery criteria, and patient-evaluated visual analog scales for sedation, anxiety, pain, and nausea were recorded, along with postdischarge emetic episodes, medications, quality of sleep, and time to resumption of food intake, normal activity, and return to work. A decision analysis tree was used to divide each data set into nine mutually exclusive subgroups, and costs and probabilities were assigned to each subgroup. The cost-effectiveness ratio was determined by summing these weighted costs and dividing by the number of patients free from both PONV and side effects of antiemetic therapy. The incidence of PONV in the hospital and after discharge, the need for rescue antiemetic therapy, and recovery and discharge times were similar for the ondansetron and both droperidol groups but differed significantly from those for the placebo group. The cost-effectiveness ratios for both droperidol 0.65 mg and 1.25 mg groups were significantly lower than those for the ondansetron and placebo groups. We conclude that droperidol 0.625 mg i.v. provides antiemetic prophylaxis comparable to that of ondansetron 4 mg i.v. without increasing side effects or delaying discharge and is most cost- effective.
This article has been cited by other articles:
|
|
 |
|
  C. W. Jackson, A. H. Sheehan, and J. G. Reddan Evidence-based review of the black-box warning for droperidol Am. J. Health Syst. Pharm., June 1, 2007; 64(11): 1174 - 1186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. F. White and H. Kehlet Postoperative Pain Management and Patient Outcome: Time to Return to Work! Anesth. Analg., March 1, 2007; 104(3): 487 - 489. [Full Text] [PDF]
|
|
|
|
 |
|
 S. M Wilhelm, M. L Dehoorne-Smith, and P. B Kale-Pradhan Prevention of Postoperative Nausea and Vomiting Ann. Pharmacother., January 1, 2007; 41(1): 68 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. F. White Update on ambulatory anesthesia Can J Anesth, June 1, 2005; 52(suppl_1): R10 - R10. [Full Text] [PDF]
|
|
|
|
|
|
P. F. White, M. A. Hamza, A. Recart, J. E. Coleman, A. R. Macaluso, L. Cox, O. Jaffer, D. Song, and R. Rohrich Optimal Timing of Acustimulation for Antiemetic Prophylaxis as an Adjunct to Ondansetron in Patients Undergoing Plastic Surgery Anesth. Analg., February 1, 2005; 100(2): 367 - 372. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Thompson and J. R. Balser Perioperative cardiac arrhythmias Br. J. Anaesth., July 1, 2004; 93(1): 86 - 94. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. F. White Prevention of Postoperative Nausea and Vomiting -- A Multimodal Solution to a Persistent Problem N. Engl. J. Med., June 10, 2004; 350(24): 2511 - 2512. [Full Text] [PDF]
|
|
|
|
|
|
K. E. Turner, J. L. Parlow, N. D. Avery, D. A. Tod, and A. G. Day Prophylaxis of Postoperative Nausea and Vomiting with Oral, Long-Acting Dimenhydrinate in Gynecologic Outpatient Laparoscopy Anesth. Analg., June 1, 2004; 98(6): 1660 - 1664. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhang, Z. Luo, and P. F. White A Model for Evaluating Droperidol's Effect on the Median QTc Interval Anesth. Analg., May 1, 2004; 98(5): 1330 - 1335. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Habib and T. J. Gan Evidence-based management of postoperative nausea and vomiting: a review: [Le traitement des nausees et des vomissements postoperatoires fonde sur des donnees probantes : une revue] Can J Anesth, April 1, 2004; 51(4): 326 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Shafer, A. S. Habib, and T. J. Gan Safety of Patients Reason for FDA Black Box Warning on Droperidol * Response Anesth. Analg., February 1, 2004; 98(2): 551 - 552. [Full Text] [PDF]
|
|
|
|
|
|
M. Dershwitz, A. S. Habib, and T. J. Gan There Should Be a Threshold Dose for the FDA Black-Box Warning on Droperidol * Response Anesth. Analg., November 1, 2003; 97(5): 1542 - 1543. [Full Text] [PDF]
|
|
|
|
|
|
O. Olutoye, E. C. Jantzen, R. Alexis, D. Rajchert, M. S. Schreiner, and M. F. Watcha A Comparison of the Costs and Efficacy of Ondansetron and Dolasetron in the Prophylaxis of Postoperative Vomiting in Pediatric Patients Undergoing Ambulatory Surgery Anesth. Analg., August 1, 2003; 97(2): 390 - 396. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Sanchez-Ledesma, L. Lopez-Olaondo, F. J. Pueyo, F. Carrascosa, and A. Ortega A Comparison of Three Antiemetic Combinations for the Prevention of Postoperative Nausea and Vomiting Anesth. Analg., December 1, 2002; 95(6): 1590 - 1595. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. F. White Droperidol: A Cost-Effective Antiemetic for Over Thirty Years Anesth. Analg., October 1, 2002; 95(4): 789 - 790. [Full Text] [PDF]
|
|
|
|
|
|
D. Song, F. Chung, S. Yogendran, and J. Wong Evaluation of postural stability after low-dose droperidol in outpatients undergoing gynaecological dilatation and curettage procedure Br. J. Anaesth., June 1, 2002; 88(6): 819 - 823. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Agarwal, N. Bose, A. Gaur, U. Singh, M. K. Gupta, and D. Singh Acupressure and ondansetron for postoperative nausea and vomiting after laparoscopic cholecystectomy: [L'acupression et l'ondansetron contre les nausees et les vomissements suivant la cholecystectomie laparoscopique] Can J Anesth, June 1, 2002; 49(6): 554 - 560. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Gan, R. Franiak, and J. Reeves Ondansetron Orally Disintegrating Tablet Versus Placebo for the Prevention of Postdischarge Nausea and Vomiting After Ambulatory Surgery Anesth. Analg., May 1, 2002; 94(5): 1199 - 1200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Zarate, M. Mingus, P. F. White, J. W. Chiu, P. Scuderi, W. Loskota, and V. Daneshgari The Use of Transcutaneous Acupoint Electrical Stimulation for Preventing Nausea and Vomiting After Laparoscopic Surgery Anesth. Analg., March 1, 2001; 92(3): 629 - 35. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Dexter, T. J. Gan, M. Naguib, and D. A. Lubarsky Cost Identification Analysis for Succinylcholine Anesth. Analg., March 1, 2001; 92(3): 693 - 699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Scuderi, R. L. James, L. Harris, and G. R. Mims III Multimodal Antiemetic Management Prevents Early Postoperative Vomiting After Outpatient Laparoscopy Anesth. Analg., December 1, 2000; 91(6): 1408 - 1414. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. Ahmed, G. J. Hobbs, and J. P. Curran Randomized, placebo-controlled trial of combination antiemetic prophylaxis for day-case gynaecological laparoscopic surgery{dagger} Br. J. Anaesth., November 1, 2000; 85(5): 678 - 682. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. S. Loewen, C. A. Marra, and P. J. Zed 5-HT3 receptor antagonists vs traditional agents for the prophylaxis of postoperative nausea and vomiting Can J Anesth, October 1, 2000; 47(10): 1008 - 1018. [Abstract] [PDF]
|
|
|
|
|
|
N. S. Kreisler, B. F. Spiekermann, C. M. Ascari, H. A. Rhyne, R. L. Kloth, L. M. Sullivan, and M. E. Durieux Small-Dose Droperidol Effectively Reduces Nausea in a General Surgical Adult Patient Population Anesth. Analg., October 1, 2000; 91(5): 1256 - 1261. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Fabling, T. J. Gan, H. E. El-Moalem, D. S. Warner, and C. O. Borel A Randomized, Double-Blinded Comparison of Ondansetron, Droperidol, and Placebo for Prevention of Postoperative Nausea and Vomiting After Supratentorial Craniotomy Anesth. Analg., August 1, 2000; 91(2): 358 - 361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Wu, S. E. Belo, and G. Koutsoukos Additive anti-emetic efficacy of prophylactic ondansetron with droperidol in out-patient gynecological laparoscopy Can J Anesth, June 1, 2000; 47(6): 529 - 536. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Henzi, J. Sonderegger, and M. R. Tramer Efficacy, dose-response, and adverse effects of droperidol for prevention of postoperative nausea and vomiting Can J Anesth, June 1, 2000; 47(6): 537 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Zarate, M. F. Watcha, P. F. White, K. W. Klein, M. S. Rego, and D. G. Stewart A Comparison of the Costs and Efficacy of Ondansetron Versus Dolasetron for Antiemetic Prophylaxis Anesth. Analg., June 1, 2000; 90(6): 1352 - 1358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. F. White and M. F. Watcha Postoperative Nausea and Vomiting: Prophylaxis Versus Treatment Anesth. Analg., December 1, 1999; 89(6): 1337 - 1337. [Full Text] [PDF]
|
|
|
|
|
|
F. Chung and G. Mezei Factors Contributing to a Prolonged Stay After Ambulatory Surgery Anesth. Analg., December 1, 1999; 89(6): 1352 - 1352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Friedberg, B. Saffran, T. J. Stinson, W. Nelson, and C. L. Bennett Evaluation of Conflict of Interest in Economic Analyses of New Drugs Used in Oncology JAMA, October 20, 1999; 282(15): 1453 - 1457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. B. Domino, E. A. Anderson, N. L. Polissar, and K. L. Posner Comparative Efficacy and Safety of Ondansetron, Droperidol, and Metoclopramide for Preventing Postoperative Nausea and Vomiting: A Meta-Analysis Anesth. Analg., June 1, 1999; 88(6): 1370 - 1370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Gan, D. A. Lubarsky, M. F. Watcha, and P. F. White Cost Effectiveness Ratio: An Often Misunderstood Term • Response Anesth. Analg., May 1, 1999; 88(5): 1191 - 1192. [Full Text] [PDF]
|
|
|
|
|
|
S. I. Marshall and F. Chung Discharge Criteria and Complications After Ambulatory Surgery Anesth. Analg., March 1, 1999; 88(3): 508 - 508. [Full Text] [PDF]
|
|
|
|
 |
|
 M. R Tramèr, D J. M Reynolds, R A. Moore, and H. J McQuay When placebo controlled trials are essential and equivalence trials are inadequate BMJ, September 26, 1998; 317(7162): 875 - 880. [Full Text]
|
|
|
